R Scatena
Overview
Explore the profile of R Scatena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wehinger B, Fiolka C, Lanza A, Scatena R, Kubus M, Grockowiak A, et al.
Phys Rev Lett
. 2018 Sep;
121(11):117201.
PMID: 30265101
We report an extraordinary pressure dependence of the magnetic interactions in the metal-organic system [CuF_{2}(H_{2}O)_{2}]_{2}pyrazine. At zero pressure, this material realizes a quasi-two-dimensional spin-1/2 square-lattice Heisenberg antiferromagnet. By high-pressure, high-field...
2.
Tellone E, Ficarra S, Scatena R, Giardina B, Kotyk A, Russo A, et al.
Physiol Res
. 2007 Aug;
57(4):621-629.
PMID: 17705675
The effects of gemfibrozil (GFZ), an antihyperlipidemic agent, on the anionic transport of the human red blood cells (RBC) during the oxygenation-deoxygenation cycle were examined. Gemfibrozil clearly plays a role...
3.
Scatena R
IDrugs
. 2005 Sep;
2(2):168-83.
PMID: 16160951
Bucindolol is a beta1 and beta2 adrenoceptor antagonist under development by Intercardia as a potential treatment for hypertension and congestive heart failure (CHF). Intercardia, Knoll AG and the NIH are...
4.
Bottoni P, Giardina B, Martorana G, Zuppi C, De Sole P, Rossi C, et al.
J Cell Mol Med
. 2005 Jun;
9(2):462-7.
PMID: 15963265
Adopting biochemical and proteomic approaches, we investigated the effect of some PPAR-agonists, a new class of differentiating agents, on human hepatocellular carcinoma Hep-G2 cell line. Cancer differentiation was assayed by...
5.
Scatena R, Bottoni P, Vincenzoni F, Messana I, Martorana G, Nocca G, et al.
Chem Res Toxicol
. 2003 Nov;
16(11):1440-7.
PMID: 14615970
Bezafibrate is a hypolipidemic drug that belongs to the group of peroxisome proliferators because it binds to peroxisome proliferator-activated receptors type alpha (PPARs). Peroxisome proliferators produce a myriad of extraperoxisomal...
6.
Gambarini G, Andreasi-Bassi M, Bolognini G, Testarelli L, Nocca G, Ceccarelli L, et al.
Aust Endod J
. 2003 May;
29(1):17-9.
PMID: 12772966
In vitro cell cultures have been widely used as a means of evaluating cytotoxicity of root canal filling materials. Following ANSI/ADA spec. no. 41, the aim of the present study...
7.
Scatena R, Giardina B
Expert Opin Biol Ther
. 2001 Dec;
1(1):121-7.
PMID: 11727541
Haemoglobin-based oxygen carriers (HBOCs) represent an interesting class of blood substitutes which are undergoing advanced clinical trials. The therapeutic goal of these compounds is to avoid or reduce blood transfusion...
8.
Scatena R
Expert Opin Investig Drugs
. 2000 Nov;
9(9):2159-65.
PMID: 11060800
Prinomastat (formerly AG3340, Agouron Pharmaceuticals, Inc.) is a potent, selective oral inhibitor of matrix metalloproteinase-2, -9, -13 and -14. This peculiar selectivity should represent an advantage for prinomastat in terms...
9.
Scatena R
Expert Opin Investig Drugs
. 2000 Nov;
9(5):1119-27.
PMID: 11060732
Bivalirudin (Angiomax, The Medicines Company) is a synthetic 20 amino acid peptide rationally designed on the basis of structural studies of hirudin, a naturally occurring anticoagulant. Bivalirudin represents a new...
10.
Scatena R, Nocca G, Sole P, Rumi C, Puggioni P, Remiddi F, et al.
Cell Death Differ
. 1999 Sep;
6(8):781-7.
PMID: 10467352
Bezafibrate belongs to the class of fibric acid derivatives usually used as antihyperlipidemia agents. From the biochemical point of view, these drugs show intriguing properties which leads one to think...